BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26174440)

  • 21. Measurement of CD8+ and CD4+ T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs.
    Sohn DH; Sohn HJ; Lee HJ; Lee SD; Kim S; Hyun SJ; Cho HI; Cho SG; Lee SK; Kim TG
    PLoS One; 2015; 10(5):e0127899. PubMed ID: 26023769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients.
    Nakid-Cordero C; Arzouk N; Gauthier N; Tarantino N; Larsen M; Choquet S; Burrel S; Autran B; Vieillard V; Guihot A
    PLoS One; 2019; 14(10):e0224211. PubMed ID: 31639143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib.
    Rumi E; Sant'Antonio E; Cavalloni C; Comolli G; Ferretti VV; Cassaniti I; Pietra D; Trotti C; Ciboddo M; Furione M; Vanni D; Casetti IC; Favaron C; Baldanti F; Arcaini L; Cazzola M
    Hematol Oncol; 2020 Oct; 38(4):554-559. PubMed ID: 32583904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
    Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
    Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
    Piriou ER; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
    Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.
    Nikiforow S; Bottomly K; Miller G
    J Virol; 2001 Apr; 75(8):3740-52. PubMed ID: 11264363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases.
    Abbott RJ; Pachnio A; Pedroza-Pacheco I; Leese AM; Begum J; Long HM; Croom-Carter D; Stacey A; Moss PAH; Hislop AD; Borrow P; Rickinson AB; Bell AI
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
    Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA
    Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
    Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
    Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
    Meij P; Bloemena E; Palmen N; Brink A; Vervoort MB; Meijer CJ; Middeldorp JM
    Cell Immunol; 2001 Feb; 208(1):25-33. PubMed ID: 11277616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes.
    Vanhoutte VJ; McAulay KA; McCarrell E; Turner M; Crawford DH; Haque T
    Immunology; 2009 Aug; 127(4):577-86. PubMed ID: 19604308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells.
    Lossius A; Johansen JN; Vartdal F; Robins H; Jūratė Šaltytė B; Holmøy T; Olweus J
    Eur J Immunol; 2014 Nov; 44(11):3439-52. PubMed ID: 25103993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus-Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma.
    Zheng Y; Parsonage G; Zhuang X; Machado LR; James CH; Salman A; Searle PF; Hui EP; Chan AT; Lee SP
    Cancer Immunol Res; 2015 Oct; 3(10):1138-47. PubMed ID: 25711537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional diversity of the CD8(+) T-cell response to Epstein-Barr virus (EBV): implications for the pathogenesis of EBV-associated lymphoproliferative disorders.
    Nazaruk RA; Rochford R; Hobbs MV; Cannon MJ
    Blood; 1998 May; 91(10):3875-83. PubMed ID: 9573025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute and chronic B cell depletion disrupts CD4+ and CD8+ T cell homeostasis and expansion during acute viral infection in mice.
    Lykken JM; DiLillo DJ; Weimer ET; Roser-Page S; Heise MT; Grayson JM; Weitzmann MN; Tedder TF
    J Immunol; 2014 Jul; 193(2):746-56. PubMed ID: 24928986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults.
    Wang Z; Kimura S; Iwasaki H; Takase K; Oshiro Y; Gamachi A; Makihara K; Ogata M; Daa T; Momosaki S; Takamatsu Y; Takeshita M
    Diagn Pathol; 2021 Jun; 16(1):48. PubMed ID: 34088321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.
    Piriou ER; van Dort K; Weel JF; Bemelman FJ; Gamadia LE; van Oers MH; van Baarle D
    Clin Immunol; 2006 Apr; 119(1):16-20. PubMed ID: 16386961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients.
    Petrova M; Muhtarova M; Nikolova M; Magaev S; Taskov H; Nikolovska D; Krastev Z
    World J Gastroenterol; 2006 Sep; 12(35):5711-6. PubMed ID: 17007027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.
    Stuhlmann-Laeisz C; Szczepanowski M; Borchert A; Brüggemann M; Klapper W
    Virchows Arch; 2015 Jan; 466(1):85-92. PubMed ID: 25339301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An analysis of immunophenotyping of peripheral lymphocytes in adult patients with infectious mononucleosis and chronic active Epstein-Barr virus infection].
    Xie J; Wang HL; Qiu ZF; Li TS
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):455-9. PubMed ID: 27256608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.